Journal of IiME Volume 6 Issue 1 (June 2012) researchers and clinicians to utilize in research and treatment. The structure of this working group, their goals and objectives and progress to date will be presented. Dr Andreas Kogelnik New Paradigms and Collaboration in the Diagnosis and Treatment of ME Dr Andreas Kogelnik is the Founding Director of the Open Medicine Institute, a collaborative, community-based translational research institute dedicated to personalized medicine with a human touch while using the latest advances in medicine, informatics, genomics, and biotechnology. The Institute works closely with the Open Medicine Clinic and other clinics to conduct research and apply new knowledge back into clinical practice. Dr. Kogelnik received his M.D. from Emory University School of Medicine in Atlanta and his Ph.D. in bioengineering/bioinformatics from the Georgia Institute of Technology. Subsequently, he completed is residency in Internal Medicine and a Fellowship in Infectious Diseases at Stanford University and its affiliated hospitals. Following his clinical training, he remained at Stanford with NIH funding to engage in postdoctoral research in microbiology, immunology and bioinformatics with Dr. Ellen Jo Baron and Dr. Stanley Falkow, where he explored host-response profiles in severely ill patients. Together with Dr. José Montoya, he was instrumental in the conception, design, and execution of the EVOLVE study - a placebocontrolled, double-blind study of a subset of chronic fatigue syndrome patients with evidence of viral infection. Dr. Kogelnik worked with Dr. Atul Butte in translational informatics to determine patterns that indicated a high risk for adverse events in Invest in ME (Charity Nr. 1114035) paediatric patients at Lucille Packard Children's Hospital. He is the Medical Director of the Open Medicine Clinic - a community-based research clinic focussed on chronic infectious diseases, neuroimmune disease, and immunology. Dr. Kogelnik has published numerous scientific papers and book chapters, is an Editor of Computers in Medicine and Biology, and is a Consulting Assistant Professor at Stanford University. With the Open Medicine Institute, he has led the formation of CFS and Lyme Registries and Biobanks as well as creating an infrastructure for providers to collect better data and implement clinical trials across a network of sites. Abstract not available. Simmaron Research Mission to play a key role in bringing science to the clinicians to better diagnose and treat patients with CFS/ME. to help fund and conduct pilot studies that have the potential of leading to the identification of diagnostic markers and potential treatments for CFS/ME and related neuroimmune disorders. to openly share our findings with the scientific and medical communities to help advance translational science that leads to the clinician’s office and ultimately improves the quality of life for people suffering from CFS/ME and related neuroimmune diseases. http://www.simmaronresearch.org Norwegian ME Association 25 Years Anniversary 2012 http://www.me-foreningen.no/ www.investinme.org Page 106 of 108
107 Publizr Home